We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Promethean | LSE:PTH | London | Ordinary Share | GB00B08H5G38 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 3.125 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:7866N
PPL Therapeutics PLC
21 July 2003
PPL Therapeutics plc ("the Company")
DISCLOSURE OF INTEREST
The Company received notification today from James Sharp & Co., that following
the purchase of 500,000 shares on 17 July 2003, Mr David Barry has an interest
in 4,050,000 Ordinary shares in the Company, representing 3.4% of the Company's
issued share capital. The shares are registered in the name of Value Investments
Limited.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUAANROKRBUAR
1 Year Promethean Chart |
1 Month Promethean Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
